In the Spotlight
CAMBRIDGE V CHICAGO:
AN ANSWER TO DR. ARNOLD RELMAN’S NEW REPUBLIC REVIEW OF OVERDOSE
Richard A. Epstein, PointofLaw.com, 8-22-07
In a recent issue of the New Republic
, Arnold Relman, a former EditorinChief of the New England Journal of Medicine
, offered a most unflattering review of my recent book, Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation
(Yale University Press, 2006). The Editors of the New Republic
have decided not to publish any reply from me. I am therefore grateful that the Manhattan Institute has stepped forward to publish my reply, withI should addan open invitation to Dr. Relman to respond if he so chooses.
Continue reading . . .
· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11
More Headlines >>
Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.
For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at email@example.com, or via telephone at 212.599.7000.
Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at firstname.lastname@example.org, or via telephone at 212.599.7000.
If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.